Category Archives: Drug use behaviours/harm reduction
Factors associated with sexual risks and risk of STIs, HIV and other blood-borne viruses among women using heroin and other drugs: A systematic literature review
2018
This systematic literature review identified factors associated with sexual risks related to sexually transmitted infections (STI), HIV and other blood-borne viruses (BBV) among women using heroin and other drugs. The...
Housing and harm reduction
2009
Key take-home messages “Some of the issues that revolve around housing readiness and access to housing being offered illustrate the “grey zones” that appear in a harm reduction approach. Thus...
Cost-effectiveness of front-line services (Updated 2010)
2010
Key take-home messages There is no one-size-fits-all cost-effective HIV strategy. An intervention that is found to be effective at preventing HIV infection has a good chance of being cost-effective due...
Sex worker HIV risk
2012
Key take-home messages The Canadian literature primarily encompasses female sex workers in Vancouver, and studies from other high income countries often addressed demographic niches that were not transferrable to the...
Public perception of harm reduction interventions
2012
Key take-home messages Public opinion polls and surveys taken between 2003 and 2007 in Ontario, Quebec, British Columbia and nationwide in Canada, have found majority support for harm reduction programs,...
Adherence to methadone maintenance treatment and antiretroviral therapy
2013
Key take-home messages HIV-positive intravenous drug users (IDUs) are at greater risk of non-adherence to highly active antiretroviral therapy (HAART) compared to the general HIV population. Psychological problems, active drug...
Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review
2018
BACKGROUND: Injection drug use (IDU) in nonurban areas of the United States is a growing public health concern, but there has been no comprehensive assessment of existing research on injection-related...
Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV?
2018
PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care...
HIV and viral hepatitis among imprisoned key populations
2018
Prisons and other closed facilities create opportunities for transmission of human immunodeficiency virus (HIV) and viral hepatitis during detention and after release. We conducted a systematic review and meta-analysis of...
Health outcomes for clients of needle and syringe programs in prisons
2018
High levels of drug dependence have been observed in the prison population globally, and the sharing of injecting drug equipment in prisons has contributed to higher prevalence of bloodborne diseases...
A systematic review of interventions by healthcare professionals to improve management of non-communicable diseases and communicable diseases requiring long-term care in adults who are homeless
2018
OBJECTIVE: Identify, describe and appraise trials of interventions delivered by healthcare professionals to manage non-communicable diseases (NCDs) and communicable diseases that require long-term care or treatment (LT-CDs), excluding mental health...
Sexualised drug use in the United Kingdom (UK): A review of the literature
2018
BACKGROUND: Sexualised drug use (SDU) refers to the use of drugs in a sexual context. This includes ‘Chemsex’- the use of drugs (specifically crystal methamphetamine, GHB/GBL and mephedrone) before or...
